GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Beximco Pharmaceuticals Ltd (DHA:BXPHARMA) » Definitions » Cyclically Adjusted PB Ratio

Beximco Pharmaceuticals (DHA:BXPHARMA) Cyclically Adjusted PB Ratio : 1.32 (As of Jun. 08, 2024)


View and export this data going back to . Start your Free Trial

What is Beximco Pharmaceuticals Cyclically Adjusted PB Ratio?

As of today (2024-06-08), Beximco Pharmaceuticals's current share price is BDT106.80. Beximco Pharmaceuticals's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was BDT80.64. Beximco Pharmaceuticals's Cyclically Adjusted PB Ratio for today is 1.32.

The historical rank and industry rank for Beximco Pharmaceuticals's Cyclically Adjusted PB Ratio or its related term are showing as below:

DHA:BXPHARMA' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0.58   Med: 1.87   Max: 3.03
Current: 1.32

During the past years, Beximco Pharmaceuticals's highest Cyclically Adjusted PB Ratio was 3.03. The lowest was 0.58. And the median was 1.87.

DHA:BXPHARMA's Cyclically Adjusted PB Ratio is ranked better than
63.88% of 742 companies
in the Drug Manufacturers industry
Industry Median: 1.875 vs DHA:BXPHARMA: 1.32

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Beximco Pharmaceuticals's adjusted book value per share data for the three months ended in Mar. 2024 was BDT104.169. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is BDT80.64 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Beximco Pharmaceuticals Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Beximco Pharmaceuticals's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beximco Pharmaceuticals Cyclically Adjusted PB Ratio Chart

Beximco Pharmaceuticals Annual Data
Trend Dec13 Dec14 Dec15 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.78 0.69 2.10 2.01 1.91

Beximco Pharmaceuticals Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.87 1.96 1.91 1.87 1.44

Competitive Comparison of Beximco Pharmaceuticals's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Beximco Pharmaceuticals's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Beximco Pharmaceuticals's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Beximco Pharmaceuticals's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Beximco Pharmaceuticals's Cyclically Adjusted PB Ratio falls into.



Beximco Pharmaceuticals Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Beximco Pharmaceuticals's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=106.80/80.64
=1.32

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Beximco Pharmaceuticals's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Beximco Pharmaceuticals's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=104.169/131.7762*131.7762
=104.169

Current CPI (Mar. 2024) = 131.7762.

Beximco Pharmaceuticals Quarterly Data

Book Value per Share CPI Adj_Book
201309 43.604 98.790 58.163
201312 44.329 98.326 59.410
201403 44.983 99.695 59.459
201406 45.086 100.560 59.082
201409 46.055 100.428 60.431
201412 46.897 99.070 62.379
201503 47.730 99.621 63.136
201506 48.266 100.684 63.171
201509 49.210 100.392 64.594
201512 0.000 99.792 0.000
201609 52.787 101.861 68.290
201612 53.698 101.863 69.467
201703 54.872 102.862 70.296
201706 56.202 103.349 71.661
201709 57.596 104.136 72.884
201712 57.970 104.011 73.445
201803 59.326 105.290 74.250
201806 60.707 106.317 75.244
201809 62.352 106.507 77.145
201812 62.860 105.998 78.147
201903 64.538 107.251 79.296
201906 66.325 108.070 80.874
201909 68.262 108.329 83.037
201912 68.783 108.420 83.600
202003 70.801 108.902 85.673
202006 72.841 108.767 88.250
202009 75.255 109.815 90.305
202012 76.447 109.897 91.667
202103 79.732 111.754 94.017
202106 83.007 114.631 95.422
202109 86.311 115.734 98.275
202112 86.655 117.630 97.077
202203 89.129 121.301 96.826
202206 91.010 125.017 95.931
202209 94.247 125.227 99.176
202212 93.522 125.222 98.417
202303 95.654 127.348 98.980
202306 97.914 128.729 100.232
202312 101.110 129.419 102.951
202403 104.169 131.776 104.169

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Beximco Pharmaceuticals  (DHA:BXPHARMA) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Beximco Pharmaceuticals Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Beximco Pharmaceuticals's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Beximco Pharmaceuticals (DHA:BXPHARMA) Business Description

Traded in Other Exchanges
Address
19 Dhanmondi, Road No. 7, Dhaka, BGD, 1205
Beximco Pharmaceuticals Ltd is engaged in manufacturing and marketing a wide range of generic pharmaceutical formulation products, life-saving intravenous fluids, therapeutic nutrition products, and Active Pharmaceutical Ingredients. It manufactures various pharmaceutical products including oral contraceptives, hormones, steroids, anti-histamine, anti-fibrinolytic, cardiac, musculoskeletal, respiratory, vitamin & mineral supplements, women's health products, and others. The products of the company are sold in domestic and international markets. Key revenue accrues from local sales.

Beximco Pharmaceuticals (DHA:BXPHARMA) Headlines

No Headlines